Sonnet Biotherapeutics Receives Shareholder Approval to Merge with Hyperliquid Strategies
By: theblockbeats.news|2025/12/02 14:45:54
Udostępnij
BlockBeats News, December 2nd, According to market sources, Sonnet Biotherapeutics has received shareholder approval to merge with Hyperliquid Strategies.
Previously reported, Hyperliquid Strategies plans to raise up to $1 billion, intended to be used to purchase HYPE, etc.
Popularne monety
Najnowsze wiadomości kryptowalutowe
Obsługa klienta:@weikecs
Współpraca biznesowa:@weikecs
Quant trading i MM:[email protected]
Usługi VIP:[email protected]